News articles about National Health Investors (NYSE:NHI) have trended somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. National Health Investors earned a news sentiment score of 0.18 on Accern’s scale. Accern also gave news coverage about the real estate investment trust an impact score of 46.7011213375449 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

These are some of the news articles that may have effected Accern Sentiment’s rankings:

NHI has been the topic of several recent research reports. Zacks Investment Research upgraded National Health Investors from a “hold” rating to a “buy” rating and set a $86.00 price target on the stock in a report on Thursday, September 28th. Mizuho reiterated a “hold” rating and issued a $82.00 price target on shares of National Health Investors in a report on Wednesday, October 4th. SunTrust Banks initiated coverage on National Health Investors in a report on Tuesday, October 10th. They issued a “hold” rating and a $80.00 price target on the stock. Capital One Financial initiated coverage on National Health Investors in a research note on Monday, October 23rd. They issued an “equal weight” rating for the company. Finally, KeyCorp reissued a “hold” rating on shares of National Health Investors in a research note on Sunday, September 17th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $80.14.

National Health Investors (NYSE:NHI) traded down $0.27 during trading on Friday, reaching $75.99. 166,765 shares of the company were exchanged, compared to its average volume of 212,003. The company has a debt-to-equity ratio of 0.84, a current ratio of 12.72 and a quick ratio of 12.72. National Health Investors has a 12 month low of $68.96 and a 12 month high of $81.60. The stock has a market cap of $3,140.00, a price-to-earnings ratio of 19.00, a P/E/G ratio of 3.74 and a beta of 0.59.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Friday, December 29th will be given a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a dividend yield of 5.00%. The ex-dividend date is Thursday, December 28th. National Health Investors’s dividend payout ratio (DPR) is presently 95.00%.

TRADEMARK VIOLATION WARNING: This piece was posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this piece can be read at https://theolympiareport.com/2017/12/24/national-health-investors-nhi-earns-news-sentiment-rating-of-0-18.html.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Insider Buying and Selling by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.